I'm a hematology/oncology fellow at the University of Pennsylvania. My work combines clinical investigation in genitourinary cancers with the design and rigorous evaluation of AI-enabled interventions — tools built to improve patient-centered outcomes, tested with pragmatic clinical trials.
I'm half-Japanese and split my childhood between the D.C. area and Tokyo (see my Japan recs for the places I keep going back to). I graduated from both college and medical school at the University of Chicago and did my internal medicine residency at UC San Francisco.
My research starts with clinical problems I see in GU oncology — patients who leave clinic without understanding their treatment plan, conversations about goals of care that happen too late, populations excluded from landmark trials. I build digital and AI-enabled interventions to address those gaps, then evaluate them the way we would any therapeutic: prospective designs, patient-centered endpoints, pragmatic trials.
OncoEducate uses generative AI to create personalized, plain-language summaries of treatment plans for patients with cancer. A pilot study in GU oncology is published in The Oncologist; a randomized controlled trial is in development, with grant applications under review.
OncoEducateFutureWise is a digital platform that helps prime patients for serious illness conversations before they happen in clinic. Developed through Penn's Innovation Corps and currently in pilot testing, the goal is an implementation trial embedded in routine oncology care.
FutureWiseOutcomes research in advanced urothelial cancer, including treatment effectiveness in populations underrepresented in pivotal trials. Investigator-initiated trial work in metastatic kidney cancer studying consolidative approaches to oligometastatic disease.
Bladder & Kidney Cancer